最新動態

最新報告

最新白皮書

最新文章

2025/4/1 文章

The Biggest Challenge in Running a Chronic Hepatitis B Trial is Often Patient Recruitment

Something that you wouldn’t really expect for a disease with over 250 million people infected worldwide. However, the areas where...

報告
2025/3/27 文章

Novotech Expands South Korean Presence with New Hospital Trial Site Deal

In a recent feature from Clinical Insider, Novotech announced a strategic partnership with Kyungpook National University Hospit...

報告
2025/3/26 文章

Bladder Cancer: Challenges, Innovations, and Opportunities for Primary Care Physicians

In a recent article from Medical Economics, Sarah Anderson, Novotech’s Therapeutic Strategy Lead – Oncology, outlines the evolv...

報告
2025/2/19 文章

Navigating the Future of Clinical Trials: Expert Insights for 2025

Expert Outlook: Scott Schliebner on the Future of Clinical Trials in 2025As featured in Scrip | “Scrip Asks......

報告
2025/2/5 文章

疫苗臨床試驗聚焦東南亞帶來的「獨特」機遇

受託研究機構 (CRO) Novotech臨床服務資深總監Chris Chong表示,東南亞為委託者進行候選疫苗臨床試驗提供獨特機遇,包括受試者招募速度更快、成本更低、免疫率更高。 ...

報告
2024/12/19 文章

引領臨床試驗邁向成功:韓國生技公司進軍歐洲市場的核心要點

2024年7月,來自Bridge Biotherapeutics、AriBio和Novotech的領導高層齊聚首爾,共同探討在歐洲進行臨床試驗所面臨的監管和營運挑戰。這次圓桌會議討論的重點是根據成本、時間和品質選擇試驗地點。...

報告

最新案例研究